On the one hand, VEGF was demonstrated to drive cardiac hypertrophy [32] whereby, on the other hand, VEGF-mediated hypertrophy regression was largely attributed to its ability to increase cardiac angiogenesis [33, 34]. The gene discussed is VEGFA; the disease is hypertrophy.